258 related articles for article (PubMed ID: 20219827)
1. Losartan increases NO release in afferent arterioles during regression of L-NAME-induced renal damage.
Helle F; Iversen BM; Chatziantoniou C
Am J Physiol Renal Physiol; 2010 May; 298(5):F1170-7. PubMed ID: 20219827
[TBL] [Abstract][Full Text] [Related]
2. Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism.
Helle F; Jouzel C; Chadjichristos C; Placier S; Flamant M; Guerrot D; François H; Dussaule JC; Chatziantoniou C
Am J Physiol Renal Physiol; 2009 Jul; 297(1):F191-9. PubMed ID: 19420116
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
4. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II sensitivity of afferent glomerular arterioles in endothelin-1 transgenic mice.
Patzak A; Bontscho J; Lai E; Kupsch E; Skalweit A; Richter CM; Zimmermann M; Thöne-Reineke C; Joehren O; Godes M; Steege A; Hocher B
Nephrol Dial Transplant; 2005 Dec; 20(12):2681-9. PubMed ID: 16188896
[TBL] [Abstract][Full Text] [Related]
6. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
Banting JD; Friberg P; Adams MA
J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of selective and non-selective nitric oxide synthase inhibition in gentamicin-induced rat nephrotoxicity.
Ghaznavi R; Kadkhodaee M
Arch Toxicol; 2007 Jun; 81(6):453-7. PubMed ID: 17039356
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
10. Contribution of the endothelin and renin-angiotensin systems to the vascular changes in rats chronically treated with ouabain.
Xavier FE; Yogi A; Callera GE; Tostes RC; Alvarez Y; Salaices M; Alonso MJ; Rossoni LV
Br J Pharmacol; 2004 Nov; 143(6):794-802. PubMed ID: 15477225
[TBL] [Abstract][Full Text] [Related]
11. Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations.
Verhagen AM; Braam B; Boer P; Gröne HJ; Koomans HA; Joles JA
Kidney Int; 1999 Jul; 56(1):222-31. PubMed ID: 10411696
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
[TBL] [Abstract][Full Text] [Related]
13. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
Zhou X; Matavelli LC; Ono H; Frohlich ED
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
Anderson IK; Drew GM
Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
[TBL] [Abstract][Full Text] [Related]
15. Changes in angiotensin receptors expression play a pivotal role in the renal damage observed in spontaneously hypertensive rats.
Landgraf SS; Wengert M; Silva JS; Zapata-Sudo G; Sudo RT; Takiya CM; Pinheiro AA; Caruso-Neves C
Am J Physiol Renal Physiol; 2011 Feb; 300(2):F499-510. PubMed ID: 21084406
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin.
Chatziantoniou C; Boffa JJ; Ardaillou R; Dussaule JC
J Clin Invest; 1998 Jun; 101(12):2780-9. PubMed ID: 9637712
[TBL] [Abstract][Full Text] [Related]
17. Effects of angiotensin II type 1 receptor blockade on the systemic blood nitric oxide dynamics in Nomega-nitro-L-arginine methyl ester-treated rats.
Kanematsu Y; Tsuchiya K; Ohnishi H; Motobayashi Y; Izawa Y; Ishihara M; Ishizawa K; Abe S; Kawazoe K; Tamaki T
Hypertens Res; 2006 May; 29(5):369-74. PubMed ID: 16832158
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
[TBL] [Abstract][Full Text] [Related]
19. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
Uhlenius N; Vuolteenaho O; Tikkanen I
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
[TBL] [Abstract][Full Text] [Related]
20. Effects of long-term losartan and L-arginine treatment on haemodynamics, glomerular filtration, and SOD activity in spontaneously hypertensive rats.
Miloradović Z; Jovović D; Mihailović-Stanojević N; Milanović JG; Milanović S
Can J Physiol Pharmacol; 2008 Apr; 86(4):210-4. PubMed ID: 18418431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
